Carregant...
Tau spread, apoE, inflammation, and more: Rapidly evolving basic science in AD
To date, Alzheimer's disease (AD) drug candidates have produced negative results in human trials and progress moving new targets out of the laboratory and into trials has been slow. However, based on three decades of previous work, there is reason to hope that amyloid-based and other novel ther...
Guardat en:
| Publicat a: | Neurol Clin |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417853/ https://ncbi.nlm.nih.gov/pubmed/28410655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ncl.2017.01.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|